Prosecution Insights
Prosecution Insights
45 pending office actions • 38 clients • 44 examiners • 34 art units • 0 of 45 (0%) have an AI response strategy ready • 53 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 45 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 45 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 33 (73%) |
| §102 only | 4 (9%) |
| §112 only | 4 (9%) |
| Double-patenting + other | 1 (2%) |
| No statute on record | 3 (7%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BASQUILL, SEAN M | 2 | 38.6% | +22.5% |
| SINGH, ANOOP KUMAR | 1 | 42.8% | +67.6% |
| ING, MATTHEW W | 1 | 64.8% | +7.6% |
| CAJILIG, CHRISTINE T | 1 | 70.7% | +14.8% |
| MACCRATE, NICOLE PAIGE | 1 | 56.7% | +23.2% |
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 0.0% | +0.0% |
| DO, ROWLAND | 1 | 70.0% | -5.7% |
| CAMPBELL, NATASHA N. | 1 | 67.6% | +14.2% |
| PARIHAR, PRADHUMAN | 1 | 55.9% | +21.3% |
| MI, QIUWEN | 1 | 68.2% | +49.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701596 | OPTIMIZED BIOSYNTHESIS PATHWAY FOR CANNABINOID BIOSYNTHESIS | LOUNTOS, GEORGE THEMISTOCLIS | 84d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17383941 | METHODS AND DEVICES FOR REPAIR OF CRUSHED PERIPHERAL NERVE INJURIES WITH ERYTHROPOIETIN | BASQUILL, SEAN M | 24d overdue |
| 18817610 | SELF-CENTERING ENERGY DISSIPATION DEVICE AND WALL DAMPING ASSEMBLY | CAJILIG, CHRISTINE T | 7d |
| 18545168 | REUSABLE FOOD OR BEVERAGE CONTAINER SANITIZING AND WASHING SYSTEM | PARIHAR, PRADHUMAN | 14d |
| 18949619 | CELLS LACKING B2M SURFACE EXPRESSION AND METHODS FOR ALLOGENEIC ADMINISTRATION OF SUCH CELLS | SINGH, ANOOP KUMAR | 34d |
| 18294929 | CLEAN-IN-PLACE (CIP) SYSTEM AND PROCESS | CAMPBELL, NATASHA N. | 40d |
| 18571123 | NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS | MI, QIUWEN | 46d |
| 18020234 | A COMPOSITON COMPRISING MICROCAPSULES | BASQUILL, SEAN M | 49d |
| 18714937 | A PROCESS AND SYSTEM FOR LINE PRODUCING SEED FILLED PLANT GROWTH MEDIUM POTS, RODS, OR BANDS | MACCRATE, NICOLE PAIGE | 76d |
| Art Unit | Apps |
|---|---|
| 1632 | 5 |
| 1658 | 3 |
| 1714 | 2 |
| 1611 | 2 |
| 1633 | 2 |
| 1614 | 2 |
| 1618 | 2 |
| 3637 | 1 |
| 3633 | 1 |
| 3642 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18949619 | CELLS LACKING B2M SURFACE EXPRESSION AND METHODS FOR ALLOGENEIC ADMINISTRATION OF SUCH CELLS | President and Fellows of Harvard College | SINGH, ANOOP KUMAR | 1632 | §112 | Final Rejection | 34d | Pending | Nov 15, 2024 |
| 18931358 | OUTDOOR TABLETOP SYSTEM | Agio International Company, Limited | ING, MATTHEW W | 3637 | §103 | Non-Final OA | 15d overdue | Pending | Oct 30, 2024 |
| 18817610 | SELF-CENTERING ENERGY DISSIPATION DEVICE AND WALL DAMPING ASSEMBLY | National Applied Research Laboratories | CAJILIG, CHRISTINE T | 3633 | §103 | Non-Final OA | 7d | Pending | Aug 28, 2024 |
| 18714937 | A PROCESS AND SYSTEM FOR LINE PRODUCING SEED FILLED PLANT GROWTH MEDIUM POTS, RODS, OR BANDS | Ellepot A/S | MACCRATE, NICOLE PAIGE | 3642 | §103 | Final Rejection | 76d | Pending | May 30, 2024 |
| 18701596 | OPTIMIZED BIOSYNTHESIS PATHWAY FOR CANNABINOID BIOSYNTHESIS | Cellibre, Inc. | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103 | Non-Final OA | 84d | Pending | Apr 15, 2024 |
| 18598314 | CONNECTOR ASSEMBLY AND LANYARD LOOP HAVING THE SAME | Castip Industrial Co., Ltd. | DO, ROWLAND | 3677 | §103 | Non-Final OA | 51d overdue | Pending | Mar 07, 2024 |
| 18294929 | CLEAN-IN-PLACE (CIP) SYSTEM AND PROCESS | Habi Tech. I/S | CAMPBELL, NATASHA N. | 1714 | §103 | Non-Final OA | 40d | Pending | Feb 02, 2024 |
| 18545168 | REUSABLE FOOD OR BEVERAGE CONTAINER SANITIZING AND WASHING SYSTEM | Redi Technology, Inc. | PARIHAR, PRADHUMAN | 1714 | §112 | Non-Final OA | 14d | Pending | Dec 19, 2023 |
| 18571123 | NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS | Sunregen Healthcare AG | MI, QIUWEN | 1655 | §102 | Final Rejection | 46d | Pending | Dec 15, 2023 |
| 18533542 | THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF | Academia Sinica | PHAN, DOAN THI-THUC | 1613 | §103 | Final Rejection | 23d overdue | Pending | Dec 08, 2023 |
| 18561712 | TREATMENT OF ANTIPHOSPHOLIPID SYNDROME USING S-HYDROXYCHLOROQUINE | Genovate Biotechnology Co. Ltd. | VAJDA, KRISTIN ANN | 1622 | §103 | Non-Final OA | 9d | Pending | Nov 16, 2023 |
| 18508761 | NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES | Whitehead Institute Of Biomedical Research | BERTOGLIO, VALARIE E | 1632 | Other | Non-Final OA | 85d overdue | Pending | Nov 14, 2023 |
| 18560883 | ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS | Cellibre, Inc. | SELWANES, JOHN PAUL | 1651 | §103 | Non-Final OA | 84d | Pending | Nov 14, 2023 |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | The Children's Hospital of Philadelphia | JOHNSON, KARA D | 1632 | §103 | Non-Final OA | 30d | Pending | Nov 13, 2023 |
| 18495731 | METHODS AND COMPOSITIONS FOR IN VIVO DIRECT GENOME EDITING IN PLANTS | The Regents of the University of California | KUMAR, VINOD | 1663 | §103 | Non-Final OA | 96d overdue | Pending | Oct 26, 2023 |
| 18287847 | FLOATING STRUCTURE | Seatrium (Sg) Pte. Ltd. | POLAY, ANDREW | 3615 | §103 | Non-Final OA | 4d overdue | Pending | Oct 20, 2023 |
| 18382048 | SERUM-FREE IN VITRO DIRECTED DIFFERENTIATION PROTOCOL FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF | President and Fellows of Harvard College | MONTANARI, DAVID A | 1632 | §103 | Non-Final OA | 10d overdue | Pending | Oct 19, 2023 |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | The Children's Hospital of Philadelphia | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | 61d | Pending | Oct 11, 2023 |
| 18374326 | INHIBITORS OF POSITIVE STRAND RNA VIRUSES | National Health Research Institutes | VALLE, ERNESTO | 1623 | Other | Non-Final OA | 34d | Pending | Sep 28, 2023 |
| 18231009 | METHOD FOR IMMUNE CELL TRACKING | Megapro Biomedical Co., Ltd. | LEWOCZKO, EVAN MICHAEL | 1612 | DPOther | Non-Final OA | 70d | Pending | Aug 07, 2023 |
| 18227540 | GDF11 VARIANTS AND USES THEREOF | President and Fellows of Harvard College | LEE, JIA-HAI | 1658 | §112 | Non-Final OA | 72d overdue | Pending | Jul 28, 2023 |
| 18268240 | METHODS OF CANCER DETECTION USING EXTRAEMBRYONICALLY METHYLATED CPG ISLANDS | DANA-FARBER CANCER INSTITUTE, INC. | KENNEDY, SARAH JANE | 1682 | §103 | Non-Final OA | 44d overdue | Pending | Jun 18, 2023 |
| 18209360 | POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS | Aveta Biomics, Inc. | PURDY, KYLE A | 1611 | §103 | Final Rejection | 63d | Pending | Jun 13, 2023 |
| 18035683 | METHODS | Genetix Biotherapeutics Inc. | WESTON, ALYSSA G | 1633 | §102 | Final Rejection | 62d | Pending | May 05, 2023 |
| 18034669 | DUAL TARGETING CHIMERIC ANTIGEN RECEPTORS | The University of North Carolina at Chapel Hill | SWARTWOUT, BRIANNA KENDALL | 1644 | §103 | Non-Final OA | 66d overdue | Pending | Apr 28, 2023 |
| 18135773 | PATCH SYSTEM FOR MONITORING AND ENHANCING SLEEP AND CIRCADIAN RHYTHM ALIGNMENT | Circadian Positioning Systems, Inc. | DORNA, CARRIE R | 3791 | Other | Non-Final OA | 60d overdue | Pending | Apr 18, 2023 |
| 18023086 | METHODS OF PREPARING IRON COMPLEXES | LG Bionano, LLC | LIU, SUE XU | 1616 | §103 | Non-Final OA | 23d overdue | Pending | Feb 24, 2023 |
| 18020234 | A COMPOSITON COMPRISING MICROCAPSULES | Teagasc -The Agriculture And Food Development Authority | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 49d | Pending | Feb 07, 2023 |
| 18019188 | GRIP FOR RACKET | Gripfixer Holding Aps | LEGESSE, NINI F | 3711 | §103 | Non-Final OA | 5d | Pending | Feb 01, 2023 |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | Sorbonne Universite | QIAN, CELINE X | 1637 | §103 | Non-Final OA | 28d | Pending | Dec 11, 2022 |
| 17945709 | METHOD OF BIOMARKER DETECTION IN COMPANION ANIMALS | Uni Pharma Co., LTD. | HUANG, MICKEY NMN | 1758 | §103 | Non-Final OA | 20d | Pending | Sep 15, 2022 |
| 17894333 | METHODS OF TREATING CDGSH IRON SULFUR DOMAIN 2 INSUFFICIENCY-ASSOCIATED DISORDERS | Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou | COPPINS, JANET L | 1628 | §112 | Non-Final OA | 7d | Pending | Aug 24, 2022 |
| 17786517 | METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS | President and Fellows of Harvard College | FOX, ALLISON M | 1633 | §103 | Final Rejection | 2d overdue | Pending | Jun 16, 2022 |
| 17783573 | ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER THERAPY | Shrikanta Chattopadhyay | HUDSON, AMY ROSE | 1636 | §103 | Final Rejection | 29d | Pending | Jun 08, 2022 |
| 17782908 | INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS | Nanyang Technological University | JONES, DAMERON LEVEST | 1618 | §103 | Non-Final OA | 5d overdue | Pending | Jun 06, 2022 |
| 17778382 | ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF | I-Mab | NICKOL, GARY B | 1643 | §102 | Non-Final OA | 23d overdue | Pending | May 19, 2022 |
| 17772913 | NOVEL PROLYLFK506 DERIVATIVES HAVING NEURITE GROWTH AND SYNAPSE FORMATION ACTIVITIES AND USES THEREOF | Molgenbio Co. Ltd. | RICCI, CRAIG D | 1611 | §103 | Final Rejection | 30d | Pending | Apr 28, 2022 |
| 17641059 | TRANSDUCTION EFFICIENCY ASSAY | Genetix Biotherapeutics Inc. | JADHAO, SAMADHAN JAISING | 1672 | §103 | Final Rejection | 22d overdue | Pending | Mar 07, 2022 |
| 17608463 | PEPTIDE DERIVATIVES AND CONJUGATES THEREOF FOR TREATING CANCER | The University of Sydney | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | 85d overdue | Pending | Nov 02, 2021 |
| 17598963 | METHODS TO ENHANCE T CELL REGENERATION | President and Fellows of Harvard College | BEHARRY, ZANNA MARIA | 1632 | §103 | Final Rejection | 31d overdue | Pending | Sep 28, 2021 |
| 17383941 | METHODS AND DEVICES FOR REPAIR OF CRUSHED PERIPHERAL NERVE INJURIES WITH ERYTHROPOIETIN | Shu-Tung And Alice Li Foundation Inc. | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | 24d overdue | Pending | Jul 23, 2021 |
| 17418305 | METHOD FOR STABILIZING BIOACTIVITY OF GROWTH FACTOR | National Cheng Kung University | NIEBAUER, RONALD T | 1658 | §102 | Final Rejection | 30d overdue | Pending | Jun 25, 2021 |
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | Trustees Of Boston University | GROSS, CHRISTOPHER M | 1684 | §103 | Final Rejection | 53d overdue | Pending | Feb 22, 2021 |
| 17040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Massachusetts Institute Of Technology | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | 16d | Pending | Sep 23, 2020 |
| 16924158 | RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION | Ethris GmbH | NGUYEN, QUANG | 1631 | §103 | Final Rejection | 154d overdue | Pending | Jul 08, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial